Evolution of bone marrow transplantation – the original immunotherapy-Reference-Cited by-同舟云学术

Evolution of bone marrow transplantation – the original immunotherapy

Published:2001-02 Issue:2 Volume:22 Page:88-92
ISSN:1471-4906
Container-title:Trends in Immunology
language:en
Short-container-title:Trends in Immunology

Author:

Campbell John D.M.,Cook Gordon,Holyoake Tessa L.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference38 articles.

1. Induction of chronic myelogenous leukemia in mice by the p210 bcr/abl gene of the Philadelphia chromosome;Daley;Science,1990

2. Helper and cytotoxic lymphocyte responses to chronic myeloid leukaemia: implications for adoptive immunotherapy with T cells;Lewalle;Br. J. Haematol.,1996

3. Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules;Bocchia;Blood,1995

4. b3a2 bcr-abl fusion peptides as targets for cytotoxic T cells in chronic myeloid leukaemia;Norbury;Br. J. Haematol.,2000

5. Cytotoxic T cell response against the chimeric p210 bcr-abl protein in patients with chronic myelogenous leukemia;Yotnda;J. Clin. Invest.,1998

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability and Controllability Issues in Mathematical Modeling of the Intensive Treatment of Leukemia;Journal of Optimization Theory and Applications;2015-02-27

2. Solutions of Differential–Difference Equations Arising from Mathematical Models of Granulocytopoiesis;Differential Equations and Dynamical Systems;2013-02-03

3. A PDE Model for Imatinib-Treated Chronic Myelogenous Leukemia;Bulletin of Mathematical Biology;2008-07-29

4. Modeling Imatinib-Treated Chronic Myelogenous Leukemia: Reducing the Complexity of Agent-Based Models;Bulletin of Mathematical Biology;2007-12-01

5. Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells;Blood;2007-07-15